ROYAL BANK OF CANADA - PROTARA THERAPEUTICS INC ownership

PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 32 filers reported holding PROTARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PROTARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,000
-87.5%
500
-85.4%
0.00%
Q2 2023$8,0003,420
+3320.0%
0.00%
Q1 2023$01000.0%0.00%
Q3 2022$01000.0%0.00%
Q2 2022$0
-100.0%
100
-31.5%
0.00%
Q1 2022$1,0000.0%146
-8.2%
0.00%
Q4 2021$1,000
-75.0%
159
-76.1%
0.00%
Q3 2021$4,000
-73.3%
664
-31.5%
0.00%
Q1 2021$15,000
+15.4%
969
+28.0%
0.00%
Q3 2020$13,0007570.00%
Other shareholders
PROTARA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,674,031$13,664,0004.24%
Ikarian Capital, LLC 296,426$1,515,0000.20%
DLD Asset Management, LP 229,531$1,173,0000.07%
Orbimed Advisors 830,641$4,245,0000.07%
Boxer Capital, LLC 209,227$1,069,0000.06%
Perceptive Advisors 383,526$1,960,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 64,000$327,0000.01%
Baker Brothers Advisors 199,671$1,020,0000.01%
Trexquant Investment LP 16,313$83,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 27,591$141,0000.00%
View complete list of PROTARA THERAPEUTICS INC shareholders